Combination Methotrexate and Infliximab

NCT00432432 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Chinese University of Hong Kong